Drug reference

tafamidis

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1252

Overview

Names and pronunciation

(ta-fam′id-is) Vyndamax, Vyndaqel

PDF page 1252

Functional class

Func. class.: Metabolic agent

PDF page 1252

Uses

USES: Treatment of the cardiomyopa- thy of wild-type/hereditary transthyretin- mediated amyloidosis to reduce mortality and hospitalization

PDF page 1252

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 1252

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Amyloid cardiomyopathy • Adult: PO Vyndamax: 61 mg daily; Vyndaqel: 80 mg daily

PDF page 1252

Available forms

Available forms: Capsules 20 mg (tafamidis meglumine); capsules 61 mg (tafamidis)

PDF page 1252

Dose text by age group

Adult

• Adult: PO Vyndamax: 61 mg daily; Vyndaqel: 80 mg daily

PDF page 1252

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

tafamidis

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1252

Overview

Names and pronunciation

(ta-fam′id-is) Vyndamax, Vyndaqel

PDF page 1252

Functional class

Func. class.: Metabolic agent

PDF page 1252

Uses

USES: Treatment of the cardiomyopa- thy of wild-type/hereditary transthyretin- mediated amyloidosis to reduce mortality and hospitalization

PDF page 1252

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 1252

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Amyloid cardiomyopathy • Adult: PO Vyndamax: 61 mg daily; Vyndaqel: 80 mg daily

PDF page 1252

Available forms

Available forms: Capsules 20 mg (tafamidis meglumine); capsules 61 mg (tafamidis)

PDF page 1252

Dose text by age group

Adult

• Adult: PO Vyndamax: 61 mg daily; Vyndaqel: 80 mg daily

PDF page 1252

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.